APP and early-onset autosomal dominant Alzheimer disease: Hesperidin (100 mg/kg) inhibited inflammation in an Alzheimer’s disease (AD) APP/PS1 mouse model, restored APP synthesis and Aβ peptide deposition, and improved nesting and social interactions (Li et al., 2015a).